Why scientists, academic institutions, and investors fail in bringing more products to the bedside: the Active Compass model for overcoming the innovation paradox

[1]  Y. Ilan,et al.  Role of the Immune System and the Circadian Rhythm in the Pathogenesis of Chronic Pancreatitis: Establishing a Personalized Signature for Improving the Effect of Immunotherapies for Chronic Pancreatitis. , 2020, Pancreas.

[2]  O. Villemain,et al.  Saving the endangered physician-scientists: reintroducing them to an environment of administrative support , 2020, Journal of Investigative Medicine.

[3]  Y. Ilan,et al.  Adropin as a potential mediator of the metabolic system‐autonomic nervous system‐chronobiology axis: Implementing a personalized signature‐based platform for chronotherapy , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[4]  Y. Ilan,et al.  The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugs , 2020, Seizure.

[5]  Y. Ilan,et al.  Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy , 2020, Pharmacology research & perspectives.

[6]  S. Cunningham.  3 tips for pharma startup success , 2020, Drug Discovery Today.

[7]  W. Löscher,et al.  Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options , 2020, Pharmacological Reviews.

[8]  Y. Ilan.  Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects , 2020, Molecular therapy. Methods & clinical development.

[9]  R. Jagsi,et al.  Workplace resources, mentorship, and burnout in early career physician-scientists: a cross sectional study in Japan , 2020, BMC medical education.

[10]  B. Huggett.  In conversation with four startup CEOs , 2020, Nature Biotechnology.

[11]  Y. Ilan.  Order Through Disorder: The Characteristic Variability of Systems , 2020, Frontiers in Cell and Developmental Biology.

[12]  Y. Ilan,et al.  Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents , 2020, Emerging microbes & infections.

[13]  Y. Ilan,et al.  A Personalized Signature and Chronotherapy-Based Platform for Improving the Efficacy of Sepsis Treatment , 2019, Front. Physiol..

[14]  David H. Freedman,et al.  Hunting for New Drugs with AI , 2019, Nature.

[15]  A. Iness.  Waiting to "make it" versus "making it happen": empowering physician-scientists in training. , 2019, The Journal of clinical investigation.

[16]  Y. Ilan,et al.  Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies , 2019, Front. Immunol..

[17]  K. Nakao.  Translational science: Newly emerging science in biology and medicine — Lessons from translational research on the natriuretic peptide family and leptin — , 2019, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[18]  Y. Ilan,et al.  Personalized inherent randomness of the immune system is manifested by an individualized response to immune triggers and immunomodulatory therapies: a novel platform for designing personalized immunotherapies , 2019, Immunologic Research.

[19]  H. Abelaira,et al.  Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models , 2019, Molecular Neuropsychiatry.

[20]  D. Ruffell.  The six steps to a successful start‐up: an interview with Kai Simons , 2019, FEBS letters.

[21]  John-Paul J. Yu,et al.  A physician-scientist preceptorship in clinical and translational research enhances training and mentorship , 2019, BMC Medical Education.

[22]  A. Minn,et al.  Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies. , 2018, Immunity.

[23]  Y. Ilan.  Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment , 2018, Annals of gastroenterology.

[24]  X. Wang,et al.  The Rising Challenge of Training Physician–Scientists: Recommendations From a Canadian National Consensus Conference , 2017, Academic medicine : journal of the Association of American Medical Colleges.

[25]  S. Akkerman,et al.  Professional identity in clinician‐scientists: brokers between care and science , 2017, Medical education.

[26]  Varodom Charoensawan,et al.  Bridging the gap between clinicians and systems biologists: from network biology to translational biomedical research , 2016, Journal of Translational Medicine.

[27]  John Wlodarek,et al.  Top tips for a successful practice start-up. , 2014, Journal of the Massachusetts Dental Society.

[28]  D. Rubio,et al.  Defining Translational Research: Implications for Training , 2010, Academic medicine : journal of the Association of American Medical Colleges.

[29]  Jeffrey Strovel,et al.  Early Drug Discovery and Development Guidelines: For Academic Researchers, Collaborators, and Start-up Companies , 2016 .

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..